151 related articles for article (PubMed ID: 9864290)
21. Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses.
Bouaboula M; Dussossoy D; Casellas P
J Biol Chem; 1999 Jul; 274(29):20397-405. PubMed ID: 10400664
[TBL] [Abstract][Full Text] [Related]
22. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
Glass M; Felder CC
J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
[TBL] [Abstract][Full Text] [Related]
23. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
[TBL] [Abstract][Full Text] [Related]
24. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.
Abadji V; Lucas-Lenard JM; Chin C; Kendall DA
J Neurochem; 1999 May; 72(5):2032-8. PubMed ID: 10217281
[TBL] [Abstract][Full Text] [Related]
26. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.
MacLennan SJ; Reynen PH; Kwan J; Bonhaus DW
Br J Pharmacol; 1998 Jun; 124(4):619-22. PubMed ID: 9690851
[TBL] [Abstract][Full Text] [Related]
27. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.
Rinaldi-Carmona M; Barth F; Congy C; Martinez S; Oustric D; Pério A; Poncelet M; Maruani J; Arnone M; Finance O; Soubrié P; Le Fur G
J Pharmacol Exp Ther; 2004 Sep; 310(3):905-14. PubMed ID: 15131245
[TBL] [Abstract][Full Text] [Related]
28. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
Bonhaus DW; Chang LK; Kwan J; Martin GR
J Pharmacol Exp Ther; 1998 Dec; 287(3):884-8. PubMed ID: 9864268
[TBL] [Abstract][Full Text] [Related]
29. Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.
Chin CN; Lucas-Lenard J; Abadji V; Kendall DA
J Neurochem; 1998 Jan; 70(1):366-73. PubMed ID: 9422383
[TBL] [Abstract][Full Text] [Related]
30. Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.
Begg M; Baydoun A; Parsons ME; Molleman A
J Physiol; 2001 Feb; 531(Pt 1):95-104. PubMed ID: 11179394
[TBL] [Abstract][Full Text] [Related]
31. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation.
Carayon P; Marchand J; Dussossoy D; Derocq JM; Jbilo O; Bord A; Bouaboula M; Galiègue S; Mondière P; Pénarier G; Fur GL; Defrance T; Casellas P
Blood; 1998 Nov; 92(10):3605-15. PubMed ID: 9808554
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
Hillard CJ; Manna S; Greenberg MJ; DiCamelli R; Ross RA; Stevenson LA; Murphy V; Pertwee RG; Campbell WB
J Pharmacol Exp Ther; 1999 Jun; 289(3):1427-33. PubMed ID: 10336536
[TBL] [Abstract][Full Text] [Related]
33. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
Gallate JE; Saharov T; Mallet PE; McGregor IS
Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
Holland M; John Challiss RA; Standen NB; Boyle JP
Br J Pharmacol; 1999 Oct; 128(3):597-604. PubMed ID: 10516638
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
[TBL] [Abstract][Full Text] [Related]
36. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
37. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
Bouaboula M; Poinot-Chazel C; Marchand J; Canat X; Bourrié B; Rinaldi-Carmona M; Calandra B; Le Fur G; Casellas P
Eur J Biochem; 1996 May; 237(3):704-11. PubMed ID: 8647116
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.
Felder CC; Veluz JS; Williams HL; Briley EM; Matsuda LA
Mol Pharmacol; 1992 Nov; 42(5):838-45. PubMed ID: 1331766
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of cannabinoid CB1 and CB2 receptors.
Pertwee RG
Pharmacol Ther; 1997; 74(2):129-80. PubMed ID: 9336020
[TBL] [Abstract][Full Text] [Related]
40. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
